CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

Data Compilation
#PharmaFlow

Pipeline Prospector June 2025: Sanofi, AbbVie, Eli Lilly, BioNTech lead pharma M&A spree; BMS, Astra ink major collaborations

Stock Recap
#PipelineProspector

NCGC00024675-06

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 8 USDMF, 4 CEP/COS, 2 EU WC, 1 KDMF, 6 NDC API, 6 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

53 FDF Dossiers, 11 FDA Orange Book, 31 Europe, 1 Canada, 2 South Africa, 8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 6MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 14 SPI Pharma, 9 DKSH, 1 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 1 Clariant, 10 Corel Pharma Chem, 1 Esteem Industries, 2 Finar, 5 Gangwal Chemicals, 3 Ideal Cures, 1 Ingredion Pharma Solutions, 14 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 3 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 14 Roquette, 7 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 29 Fillers, Diluents & Binders, 20 Controlled & Modified Release, 17 Film Formers & Plasticizers, 15 Taste Masking, 15 Topical, 14 Thickeners and Stabilizers, 13 Chewable & Orodispersible Aids, 12 Parenteral, 11 Direct Compression, 9 Solubilizers, 9 Empty Capsules, 8 Disintegrants & Superdisintegrants, 6 Granulation, 6 Co-Processed Excipients, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Rheology Modifiers, 3 API Stability Enhancers, 2 Emulsifying Agents, 1 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 13 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 25 Regulatory FDF Prices

MARKET PLACE

10 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM

3 EDQM

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
28/06/2025	Dasami Lab	India	Dasami Lab Private Limited	70966-0012	Nimodipine	2008-01-17	2025-12-31	BULK INGREDIENT	POWDER (1kg/kg)
28/06/2025	Lusochimica	Italy	Lusochimica SPA	43898-0117	Nimodipine	2000-07-26	2025-12-31	BULK INGREDIENT	POWDER (1kg/kg)

NCGC00024675-06

NCGC00024675-06

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

13 API Suppliers

8 USDMF

4 CEP/COS

2 EU WC

1 KDMF

6 NDC API

6 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

17 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

53 FDF Dossiers

11 FDA Orange Book

31 Europe

1 Canada

2 South Africa

8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 6MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

14 SPI Pharma

9 DKSH

1 Faran Shimi Pharmaceutical

2 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

5 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

11 BASF

1 Clariant

10 Corel Pharma Chem

1 Esteem Industries

2 Finar

5 Gangwal Chemicals

3 Ideal Cures

1 Ingredion Pharma Solutions

14 Kerry

3 Kima Chemical

6 Lonza Capsugel

3 Microlex e.U

2 Nomisma Healthcare

1 Novo Excipients

2 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

14 Roquette

7 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

2 The Dow Chemical Company

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives

29 Fillers, Diluents & Binders

20 Controlled & Modified Release

17 Film Formers & Plasticizers

15 Taste Masking

15 Topical

14 Thickeners and Stabilizers

13 Chewable & Orodispersible Aids

12 Parenteral

11 Direct Compression

9 Solubilizers

9 Empty Capsules

8 Disintegrants & Superdisintegrants

SOLUTION;ORAL - 3MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons